PLX
PLX
AMEX · Biotechnology

Protalix Biotherapeutics Inc

$3.03
-0.02 (-0.66%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +930.0% upside
Low Target $17.92
Average Target $31.21
High Target $31.70
Current Price $3.03
Current
$3.03
Target
$31.21
$17.92 $31.21 avg $31.70
Scenario Analysis
Bear Case
$17.92
491.4%
Low target
Base Case
$31.21
+930.0%
Avg target
Bull Case
$31.70
+946.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.19
-5.0% from high
52-Week Low
$1.65
+83.6% from low
Target vs 52W High
$31.21
+878.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%